The term 'catastrophic' antiphospholipid syndrome (APS) is used to define an accelerated form of APS resulting in multiorgan failure. Although catastrophic APS patients represent less than 1% of all patients with APS, they are usually in a life-threatening medical situation that requires high clinical awareness. The careful and open discussion of several proposals by all…
Lupus Template
Write in a clean editor, then format for Lupus in one click — DocuGuru applies the official SAGE template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Lupus format
Lupus is a peer-reviewed journal published by SAGE, covering Systemic Lupus Erythematosus Research, T-cell and B-cell Immunology, Monoclonal and Polyclonal Antibodies Research. Over its lifetime it has published 6,919 papers, which have received 199,245 citations.
| Publisher | SAGE |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Lupus. 2023;12(3):45–58.
Formats any DOI in Lupus style. No sign-up. |
| Publishes research in | Systemic Lupus Erythematosus Research T-cell and B-cell Immunology Monoclonal and Polyclonal Antibodies Research Atherosclerosis and Cardiovascular Diseases Rheumatoid Arthritis Research and Therapies |
| ISSN | 0961-2033 |
| Citation impact (2-yr) | 1.89 |
| h-index | 141 |
| i10-index | 4,398 |
| Top institutions publishing here | Sheba Medical Center |
| Journal website | lup.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Lupus per year
Citation impact of Lupus by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Lupus
Systemic lupus erythematosus (SLE) is a disease of multifactorial etiology. Quantifying the burden of SLE across different countries can clarify the role of genetic, environmental and other causative factors in the natural history of the disease, and to understand its clinical and societal consequences. The aim of this study is to summarize data on SLE…
The antiphospholipid syndrome (APS) is defined by the presence of thrombosis and/or pregnancy morbidity in combination with the persistent presence of circulating antiphospholipid antibodies: lupus anticoagulant, anticardiolipin antibodies and/or anti-β2-glycoprotein I antibodies in medium to high titers. The management of thrombosis in patients with APS is a subject of controversy. This set of recommendations is…
Previous studies have indicated that the autoimmune phenomenon might be caused by an imbalance of T helper cell (Th) cytokines. We measured the plasma concentrations of three novel proinflammatory cytokines interleukin (IL)-17, IL-18, IL-12 and a key Th2 cytokine IL-4 in patients with systemic lupus erythematosus (SLE) and correlated the ratio of proinflammatory/Th2 cytokines with…
The objective was to investigate the relation between serum levels of interferon-alpha (IFN-alpha), the activity of an endogenous IFN-alpha inducing factor (SLE-IIF), clinical and immunological disease activity as well as serum levels of antiretroviral antibodies in SLE. Serum levels of IFN-alpha were measured in serial sera from 30 patients sampled at different stages of disease…